Yammine L et al
And if youre using GLP-1s to support weight loss or manage Type 2 diabetes, those constant sugar spikes can seriously interfere with your goals
Discussion To date, the clinical development program suggests that lixisenatide has an appropriate pharmacodynamic action, with reductions in blood glucose, in particular marked reductions in PPG, manifesting as improvements in glycemic control, a beneficial effect on body weight, and with limited risk of hypoglycemia with 20 g OD dosing
revisiting amino acid metabolism and implications for weight loss therapy
Check the electronic Medicines Compendium (emc) at medicines.org.uk for UK-authorised product information, including Summaries of Product Characteristics (SmPCs) and Patient Information Leaflets, to confirm whether a medicine is licensed in the UK
Vijayakumar T, Sirisha G, Farzana Begam M, Dhanaraju M